189 related articles for article (PubMed ID: 10686705)
1. Glycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes.
Buysschaert M; Hermans MP
Acta Clin Belg; 1999 Dec; 54(6):328-33. PubMed ID: 10686705
[TBL] [Abstract][Full Text] [Related]
2. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
Wolffenbuttel BH; Heine RJ
Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
Vijan S; Hayward RA
Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
Alvarez Guisasola F; Mavros P; Nocea G; Alemao E; Alexander CM; Yin D
Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():8-15. PubMed ID: 18435669
[TBL] [Abstract][Full Text] [Related]
5. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain.
Al Khaja KA; Sequeira RP; Mathur VS
Ann Pharmacother; 2001 Nov; 35(11):1350-9. PubMed ID: 11724081
[TBL] [Abstract][Full Text] [Related]
6. UKPDS and the legacy effect.
Chalmers J; Cooper ME
N Engl J Med; 2008 Oct; 359(15):1618-20. PubMed ID: 18843126
[No Abstract] [Full Text] [Related]
7. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Holzgreve H; Nakov R; Beck K; Janka HU
Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
CDC Diabetes Cost-effectiveness Group
JAMA; 2002 May; 287(19):2542-51. PubMed ID: 12020335
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Blood pressure control in people with type 2 diabetes mellitus: recommendations from the American College of Physicians.
American College of Physicians
Ann Intern Med; 2003 Apr; 138(7):I70. PubMed ID: 12667047
[No Abstract] [Full Text] [Related]
11. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
12. The treatment of type 2 diabetes: good news from the UK.
Smith RB; Mann JI
N Z Med J; 1999 May; 112(1087):149-50. PubMed ID: 10378808
[No Abstract] [Full Text] [Related]
13. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus.
Snow V; Weiss KB; Mottur-Pilson C;
Ann Intern Med; 2003 Apr; 138(7):587-92. PubMed ID: 12667031
[No Abstract] [Full Text] [Related]
14. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
16. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
[TBL] [Abstract][Full Text] [Related]
17. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Turner RC; Cull CA; Frighi V; Holman RR
JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
[TBL] [Abstract][Full Text] [Related]
18. 10-year follow-up of intensive glucose control in type 2 diabetes.
Holman RR; Paul SK; Bethel MA; Matthews DR; Neil HA
N Engl J Med; 2008 Oct; 359(15):1577-89. PubMed ID: 18784090
[TBL] [Abstract][Full Text] [Related]
19. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.
Tatti P; Pahor M; Byington RP; Di Mauro P; Guarisco R; Strollo G; Strollo F
Diabetes Care; 1998 Apr; 21(4):597-603. PubMed ID: 9571349
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study.
Weber MA; Mansfield TA; Cain VA; Iqbal N; Parikh S; Ptaszynska A
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):211-220. PubMed ID: 26620248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
